Regeneron: Driven by Science
For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.
Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration07/28/15
TARRYTOWN, N.Y. and PARIS, July 28, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments in the emerging field of immuno-oncology. As part of the agreement, t...